Angiotensin Converting Enzyme Inhibitors (aceis) - Renal Disorders

Relevant Publications

Clinical spectrum, genetics and management insights of PAX2-related disorder in nine children.

Issue Release: 2025

Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study.

Issue Release: 2025

Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor.

Issue Release: 2025

Cardioprotective drugs and heart failure/cardiomyopathy incidence in chemotherapy-treated cancer survivors of breast cancer and non-Hodgkin lymphoma: a retrospective cohort study in England.

Issue Release: 2025

Up-titration of medication in patients with new-onset heart failure with and without atrial fibrillation.

Issue Release: 2025

Clinical studies in Myxomatous Mitral Valve Disease dogs: most prescribed ACEI inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma.

Issue Release: 2025

Targeted-release budesonide: A comprehensive review on its potential in IgA nephropathy.

Issue Release: 2025

Frailty and prescriptions of secondary prevention medications in older people with diabetes and coronary heart disease-An observational study in Vietnam.

Issue Release: 2025

Impact of persistence to secondary preventive medication on prognosis for patients with myocardial infarction with and without obstructive coronary arteries.

Issue Release: 2025

Changes in Phenylacetylglutamine Levels Provide Add-On Value in Risk Stratification of Hypertensive Patients: A Longitudinal Cohort Study.

Issue Release: 2025

Preoperative continuation vs. discontinuation of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers on early cognitive function in elderly patients undergoing noncardiac surgery: a randomized controlled trial.

Issue Release: 2025

Efficacy of sacubitril/valsartan on improving clinical symptoms in patients with acute myocardial infarction complicated with heart failure: a retrospective study.

Issue Release: 2025

Angiotensin-Converting Enzyme Inhibition as a Potential Risk Factor for Periprosthetic Joint Infection Following Total Knee Arthroplasty.

Issue Release: 2025

Association between sacubitril/valsartan and risk of dementia in patients with heart failure: a nationwide cohort study.

Issue Release: 2025

Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study.

Issue Release: 2025

In-Hospital Mortality and Costs of Added Morbidity in Heart Failure Patients at a University Hospital: A Retrospective Cross-Sectional Study.

Issue Release: 2025

Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes.

Issue Release: 2025

Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort.

Issue Release: 2025

Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension.

Issue Release: 2025

The impact of the COVID-19 pandemic on adverse events associated with ACEIs and ARBs: a real-world analysis using the FDA adverse event reporting system.

Issue Release: 2025

Why is GFR Important in Renal Disorders?

How is a Kidney Biopsy Performed?

What are the Benefits of Living Donation?

What are the early signs of diabetic nephropathy?

What Causes Renal Disorders?

How is CKD Diagnosed?

How are urine tests conducted?

How Is Hypertension Diagnosed in Patients with Renal Disorders?

How is Hemodialysis Performed?

What is Glomerulonephritis?

Angiotensin Converting Enzyme Inhibitors (aceis) - Renal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics